fluorodeoxyglucose F-18
Commercial- Indications
- Cancer diagnosis
Company intelligence / Profile preview
PT Global Onkolab Farma specializes in the local manufacture and development of high-quality, affordable oncology drugs—including small molecules and monoclonal antibodies—for the Indonesian market. The company has launched at least one innovative immunotherapy product for lung cancer and collaborates with both local communities and international partners to expand access to modern cancer treatments. Clinical results are positive enough to support commercial launches such as Serplulimab for lung cancer patients in Indonesia.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PT Global Onkolab Farma.